Already have an account? Sign in instead.
You stay signed in for 30 days on this browser.
Continue with Google Continue with MicrosoftNo account yet? Create a free one.
We sent a six-digit code.
It expires in ten minutes, works once, and only in this browser. Five wrong tries void it. Send another code.
Your account is live and the Cloudflare checks are off for this browser.
(a) The controlled substances listed in this Section are included in Schedule IV
Courts have cited this section in 7 opinions since 2015, 1 of them in the last five years. The most litigated part is subsection (c)(18) (2 cases).
(from Ch. 56 1/2, par. 1210) Sec. 210. (a) The controlled substances listed in this Section are included in Schedule IV. (b) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, as set forth below: (1) Not more than 1 milligram of difenoxin (DEA Drug | Code No. 9618) and not less than 25 micrograms of atropine sulfate per dosage unit. |
(2) Dextropropoxyphene (Alpha-(+)-4-dimethylamino-1, | 2-diphenyl-3-methyl-2-propionoxybutane). |
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for misuse associated with a depressant effect on the central nervous system: (1) Alprazolam; (2) Barbital; (2.1) Bromazepam; (2.2) Camazepam; (2.3) Carisoprodol; (3) Chloral Betaine; (4) Chloral Hydrate; (5) Chlordiazepoxide; (5.1) Clobazam; (6) Clonazepam; (7) Clorazepate; (7.1) Clotiazepam; (7.2) Cloxazolam; (7.3) Delorazepam; (8) Diazepam; (8.05) Dichloralphenazone; (8.1) Estazolam; (9) Ethchlorvynol; (10) Ethinamate; (10.1) Ethyl loflazepate; (10.2) Fludiazepam; (10.3) Flunitrazepam; (11) Flurazepam; (11.1) Fospropofol; (12) Halazepam; (12.1) Haloxazolam; (12.2) Ketazolam; (12.3) Loprazolam; (13) Lorazepam; (13.1) Lormetazepam; (14) Mebutamate; (14.1) Medazepam; (15) Meprobamate; (16) Methohexital; (17) Methylphenobarbital (Mephobarbital); (17.1) Midazolam; (17.2) Nimetazepam; (17.3) Nitrazepam; (17.4) Nordiazepam; (18) Oxazepam; (18.1) Oxazolam; (19) Paraldehyde; (20) Petrichloral; (21) Phenobarbital; (21.1) Pinazepam; (22) Prazepam; (22.1) Quazepam; (23) Temazepam; (23.1) Tetrazepam; (23.2) Tramadol; (24) Triazolam; (24.5) Zaleplon; (25) Zolpidem; (26) Zopiclone. (d) Any material, compound, mixture, or preparation which contains any quantity of the following substances, including its salts, isomers (whether optical, position, or geometric), and salts of such isomers, whenever the existence of such salts, isomers and salts of isomers is possible: (1) Fenfluramine. (e) Unless specifically excepted or unless listed in another schedule any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation: (1) Cathine ((+)-norpseudoephedrine); (1.1) Diethylpropion; (1.2) Fencamfamin; (1.3) Fenproporex; (2) Mazindol; (2.1) Mefenorex; (3) Phentermine; (4) Pemoline (including organometallic complexes and | chelates thereof); |
(5) Pipradrol; (6) SPA ((-)-1-dimethylamino-1, 2-diphenylethane); (7) Modafinil; (8) Sibutramine. (f) Other Substances. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation that contains any quantity of the following substance, including its salts: (1) Butorphanol (including its optical isomers). (g) The Department may except by rule any compound, mixture, or preparation containing any depressant substance listed in subsection (b) from the application of all or any part of this Act if the compound, mixture, or preparation contains one or more active medicinal ingredients not having a depressant effect on the central nervous system, and if the admixtures are included therein in combinations, quantity, proportion, or concentration that vitiate the potential for misuse of the substances which have a depressant effect on the central nervous system. (h) Except as otherwise provided in Section 216, any material, compound, mixture, or preparation that contains any quantity of the following substance having a stimulant effect on the central nervous system, including its salts, enantiomers (optical isomers) and salts of enantiomers (optical isomers): (1) Ephedrine, its salts, optical isomers and salts | of optical isomers. |
(Source: P.A. 103-881, eff. 1-1-25.) The 7 cases that cite 720 ILCS 570/210 most heavily, weighted by court and treatment.
RelevanceNewestTreatment
1
GREENJulio Najera-Rodriguez v. William P. Barr, 926 F.3d 343 (7th Cir. 2019).
2
GREENWalker v. Dart, 2015 IL App (1st) 140087, 30 N.E.3d 426.
3
NEUTRALPeople v. Brantley, 2016 IL App (5th) 150177.
4
GREENWalker v. Dart, 2015 IL App (1st) 140087, 30 N.E.3d 426.
5
GREENJulio Najera-Rodriguez v. William P. Barr, No. 18-2416 (7th Cir. June 4, 2019).
6
GREENJulio Najera-Rodriguez v. William P. Barr, No. 18-2416 (7th Cir. June 4, 2019).
7
NO FLAGPeople v. Ordner, 2025 IL App (5th) 230216-U.
The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus. Citing cases by year 201520202025 One bar per year. Tallest: 3 cases in 2019. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation. By court By subsection
(c)(1)1 casePeople v. Brantley, 2016 IL App (5th) 150177.“He submitted to blood and urine testing, which revealed the presence of alprazolam, a controlled substance listed as a Schedule IV drug in the Illinois Controlled Substances Act (720 ILCS 570/210(c)(1) (West 2014)). A statutory summary suspension was scheduled to go into effect…”
(c)(18)2 casesWalker v. Dart, 2015 IL App (1st) 140087, 30 N.E.3d 426.“Plaintiff's sample tested positive for oxazepam, which is a benzodiazephine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
Walker v. Dart, 2015 IL App (1st) 140087, 30 N.E.3d 426.“Plaintiff’s sample tested positive for oxazepam, which is a benzodiazepine and is a controlled substance under schedule IV of the Illinois Controlled Substances Act (720 ILCS 570/210(c)(18) (West 2010)). Following the positive result, an investigation was opened and a complaint…”
Enactment and amendments Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end. Versions Edition shown: laws through the 2026 session (checked Sept. 2026). Syfert holds no earlier or later version of this section. |